Bioqual, Inc. (BIOQ)

Bioqual Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Net Income	-	0.84	5.26	6.33	4.23
Depreciation & Amortization	-	5.83	8.19	4.45	4.28
Stock-Based Compensation	-	-	-	0	0.01
Other Operating Activities	-	-0.01	0.15	-0.41	0.14
Change in Accounts Receivable	-	6.12	-6.66	-5.66	-3.02
Change in Accounts Payable	-	-1.7	1.18	-0.37	1.16
Change in Unearned Revenue	-	-0.21	0.29	0.05	0.56
Change in Income Taxes	-	-	-0.08	0.27	-0.09
Change in Other Net Operating Assets	-	-2.65	-8.02	-2.52	-3.2
Operating Cash Flow	-	8.23	0.31	2.14	4.08
Operating Cash Flow Growth	-	2526.34%	-85.36%	-47.52%	140.23%
Capital Expenditures	-	-2.24	-4.89	-4.4	-2.4
Sale of Property, Plant & Equipment	-	0	-	-	-
Other Investing Activities	-	-	0.15	0.71	-
Investing Cash Flow	-	-2.24	-4.73	-3.69	-2.4
Common Dividends Paid	-	-0.89	-1.12	-0.98	-0.63
Financing Cash Flow	-	-0.89	-1.12	-0.98	-0.63
Net Cash Flow	-	5.1	-5.54	-2.54	1.05
Free Cash Flow	-	5.99	-4.57	-2.26	1.67
Free Cash Flow Margin	-	9.55%	-6.91%	-3.92%	3.61%
Free Cash Flow Per Share	-	6.69	-5.11	-2.53	1.87
Cash Interest Paid	-	-	-	-	0.01
Cash Income Tax Paid	-	1.46	2.31	2.34	1.14
Levered Free Cash Flow	-	9.33	0.92	0.2	3.3
Unlevered Free Cash Flow	-	9.33	0.92	0.2	3.31
Change in Working Capital	-	1.57	-13.28	-8.23	-4.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.